Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zyvex Labs is a nanotechnology research and development company based in Richardson, Texas, specializing in atomically precise manufacturing (APM). Founded as a successor to the original Zyvex Corporation—the world's first molecular nanotechnology company—Zyvex Labs focuses on developing tools and techniques to build structures with atomic-level control. Their primary commercial offering, the ZyVector, is a control system for scanning tunneling microscopes that enables automated hydrogen depassivation lithography for quantum and semiconductor applications. While their current revenue is driven by high-precision instrumentation, the company maintains a long-term focus on nanomedicine, including the development of molecular robots and advanced diagnostic systems. Zyvex Labs is a key participant in the Nanofactory Collaboration, aiming to realize the vision of a functional molecular assembler for medical and industrial use.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zyvex.